"Flagship Gene Therapy Startup Ring Therapeutics Cuts Staff by 20%"
Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has laid off nearly 20% of its staff, totaling 19 employees, as part of a broader trend of platform companies hunkering down due to scarce funding for private biotechs. The company, known for its ambitious efforts to engineer a new class of viruses for gene delivery, has had to make tough choices on staffing and priorities in the face of the expensive and setback-ridden process of developing new technologies.